Title of Invention

"RECOMBINANT NUCLEIC ACID MOLECULE, VECTOR COMPRISING IT AND POLYPEPTIDE ENCODED BY IT

Abstract

ABSTRACT IT AND POLYPEPTIDE ENCODED BY IT" The invention discloses a recombinant nucleic acid molecule encoding a 5- enolpyruvylshikimate-3-phosphate synthase enzyme selected from the group consisting of: a) a nucleic acid molecule comprising the nucleotide sequence of SEQ ID NO:1 or 2, or a complement thereof; b) a nucleic acid molecule comprising a nucleotide sequence having at least 95% sequence identity to the nucleotide sequence of SEQ ID NO: 1 or 2, or a complement thereof, wherein said nucleotide sequence encodes a polypeptide having herbicide resistance activity; c) the herbicide resistance nucleotide sequence of the DNA insert of the plasmid deposited as Accession No. NRRL B-30804, or a complement thereof; d) a nucleic acid molecule which encodes a polypeptide comprising the amino acid sequence of SEQ ID NO:3; and, e) a nucleic acid molecule comprising a nucleotide sequence encoding a polypeptide having at least 95% amino acid sequence identity to the amino acid sequence of SEQ ID NO:3, wherein said polypeptide has herbicide resistance activity. The invention is also for a vector comprising said molecule and a polypeptide encoded by it having herbicide resistance.

Full Text

WO 2006/110188 PCT/US2005/046608 "RECOMBINANT NUCLEIC ACID MOLECULE, VECTOR COMPRISING IT AND POLYPEPTIDE ENCODED BY IT" This invention provides a novel gene encoding a 5-enolpyruvylshikimate-3- phosphate (EPSP) synthase that provides herbicide resistance, and variants thereof. This gene and its variants are useful in plant biology, crop breeding, and plant cell culture. BACKGROUND OF THE INVENTION N-phosphonomethylglycine, commonly referred to as glyphosate, is an important agronomic chemical. Glyphosate inhibits the enzyme that converts phosphoenolpyruvic acid (PEP) and 3-phosphoshikimic acid to 5-enolpyruvyl-3- phosphoshikrrnic acid. Inhibition of this enzyme (5-enolpyruvylshikimate-3- phosphate synthase; referred to herein as "EPSP synthase") kills plant cells by shutting down the shikimate pathway, thereby inhibiting aromatic amino acid biosynthesis. Since glyphosate-class herbicides inhibit arpmatic amino acid biosynthesis, they not only kill plant cells, but are also toxic to bacienal cells. Glyphosate inhibits many bacterial EPSP synthases, and thus is toxic to these bacteria. However, certain bacterial EPSP synthases have a high tolerance to glyphosate. Plant cells resistant to glyphosate toxicity can be produced by transforming plant cells to express glyphosate-resistant bacterial EPSP synthases. Notably, the bacterial gene from Agrobacterium tumefaciens strain CP4 has been used to confer herbicide resistance on plant cells following expression in plants. A mutated EPSP synthase from Salmonella typhimurium strain CT7 confers giyphosate resistance in bacterial cells, and confers glyphosate resistance on plant cells (U.S. Patent Nos. 4,535,060; 4,769,061; and 5,094,945). However, there is a need for other herbicide resistance genes. BRIEF SUMMARY OF THE INVENTION Compositions and methods for conferring herbicide resistance to bacteria, plants, plant cells, tissues and seeds are provided. Compositions include nucleic acid l WO 2006/110188 PCT/US2005/046608 molecules encoding sequences for herbicide resistance polypeptides, vectors comprising those nucleic acid molecules, and host cells comprising the vectors. Compositions comprising a coding sequence for a polypeptide that confers resistance or tolerance to glyphosate herbicides are provided, as well as antibodies to the polypeptides. Compositions of the present invention include synthetic nucleic acid molecules encoding herbicide resistance polypeptides. The coding sequences can be used in DNA constructs or expression cassettes for transformation and expression in organisms, including microorganisms and plants. Compositions also comprise transformed bacteria, plants, plant cells, tissues, and seeds. In addition, methods are provided for producing the polypeptides encoded by the synthetic nucleotides of the invention. In particular, isolated nucleic acid molecules corresponding to herbicide resistance-conferring nucleic acid sequences are provided. Additionally, amino acid sequences corresponding to the polynucleotides are encompassed. In particular, the present invention provides for isolated nucleic acid molecules comprising the nucleotide sequence set forth in SEQ ID NO:1 or 2, a nucleotide sequence encoding the amino acid sequence shown in SEQ ID NO:3, the herbicide resistance nucleotide sequence deposited in a hacterial host as Accession No. B-30804, as well as variants and fragments thereof. Nucleotide sequences that are complementary to a nucleotide sequence of the invention, or that hybridize to a sequence of the invention are also encompassed. BRIEF DESCRIPTION OF FIGURES Figure 1 shows the nucleotide sequence of grg8 (SEQ ID NO:1). The open reading frame starts at nucleotide 296 and ends at nucleotide 1555 (SEQ ID NO:2). Figure 2 shows the amino acid sequence of GRG8 protein (SEQ ID NO:3). Figure 3 shows an alignment of the amino acid sequences of GRG8 (SEQ ID NO:3), GRG8ml_(C22) (SEQ ID NO:5), GRG8m3_(N24) (SEQ ID NO:9), GRG8m2_(N15) (SEQ ID NO:7), GRG8m4_(Al) (SEQ ID NO: 11), GRG8m5_(B2) (SEQ ID NO: 13), GRG8m6_(B7) (SEQ ID NO: 15), GRG8m7_(B11) (SEQ ID NO.17), GRG8m8_(Cll) (SEQ ID NO: 19), GRG8m9_(E3) (SEQ ID NO:21), and GRG8ml0_(E4) (SEQ ID NO:23). 2 WO 2006/110188 PCT/US2005/046608 DETAILED DESCRIPTION OF THE INVENTION The present inventions now will be described more fully hereinafter with reference to the accompanying drawings, in which some, but not all embodiments of the inventions are shown. Indeed, these inventions may be embodied in many different forms and should not be construed as limited to the embodiments set forth herein; rather, these embodiments are provided so that this disclosure will satisfy applicable legal requirements. Like numbers refer to like elements throughout. Many modifications and other embodiments of the inventions set forth herein will come to mind to one skilled in the art to which these inventions pertain having the benefit of the teachings presented in the foregoing descriptions and the associated drawings. Therefore, it is to be understood that the inventions are not to be limited to the specific embodiments disclosed and that modifications and other embodiments are intended to be included within the scope of the appended claims. Although specific terms are employed herein, they are used in a generic and descriptive sense only and not for purposes of limitation. The present invention is drawn to compositions and methods for regulating herbicide resistance in organisms, particularly in plants or plant cells. The methods involve, transforming organisms with nucleotide sequences encodingiheglyphosate. resistance gene of the invention. The nucieotide sequences of the invention arc useful for preparing plants that show increased tolerance to the herbicide glyphosate. Thus, transformed bacteria, plants, plant cells, plant tissues and seeds are provided. Compositions include nucleic acids and proteins relating to herbicide tolerance in microorganisms and plants as well as transformed bacteria, plants, plant tissues and seeds. Nucieotide sequences of the glyphosate resistance gene (grg8) and the amino acid sequences of the proteins encoded thereby are disclosed. The sequences find use in the construction of expression vectors for subsequent transformation into plants of interest, as probes for the isolation of other glyphosate resistance genes, as selectable markers, and the like. Plasmids containing the herbicide resistance nucieotide sequences of the invention were deposited in the permanent collection of the Agricultural Research Service Culture Collection, Northern Regional Research Laboratory (NRRL) on December 21,2004, and assigned Accession No. NRRL B-30804. This deposit will 3 WO 2006/110188 PCT/US2005/046608 be maintained under the terms of the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure. This deposit was made merely as a convenience for those of skill in the art and is not an admission that a deposit is required under 35 U.S.C. §112. By "glyphosate" is intended any herbicidal form of N- phosphonomethylglycine (including any salt thereof) and other forms that result in the production of the glyphosate anion in planta. An "herbicide resistance protein" or a protein resulting from expression of an "herbicide resistance-encoding nucleic acid molecule" includes proteins that confer upon a cell the ability to tolerate a higher concentration of an herbicide than cells that do not express the protein, or to tolerate a certain concentration of an herbicide for a longer time than cells that do not express the protein. A "glyphosate resistance protein" includes a protein that confers upon a cell the ability to tolerate a higher concentration of glyphosate than cells that do not express the protein, or to tolerate a certain concentration of glyphosate for a longer period of time than cells that do not express the protein. By "tolerate" or "tolerance" is intended either to survive, or to carry out essential cellular functions such as protein synthesis and respiration in a manner that is not readily discemable from untreated cells. Isolated Nucleic Acid Molecules, and Variants and Fragments Thereof One aspect of the invention pertains to isolated nucleic acid molecules comprising nucleotide sequences encoding herbicide resistance proteins and polypeptides or biologically active portions thereof, as well as nucleic acid molecules sufficient for use as hybridization probes to identify herbicide resistance-encoding nucleic acids. As used herein, the term "nucleic acid molecule" is intended to include DNA molecules (e.g., cDNA or genomic DNA) and RNA molecules (e.g., mRNA) and analogs of the DNA or RNA generated using nucleotide analogs. The nucleic acid molecule can be single-stranded or double-stranded. Nucleotide sequences encoding the proteins of the present invention include the sequences set forth in SEQ ID NOS: 1 and 2, the herbicide resistance nucleotide sequence deposited in a bacterial host as Accession No. NRRL B-30804, and variants, fragments, and complements thereof. By "complement" is intended a nucleotide 4 WO 2006/110188 PCT/US2005/046608 sequence that is sufficiently complementary to a given nucleotide sequence such that it can hybridize to the given nucleotide sequence to thereby form a stable duplex. The corresponding amino acid sequence for the herbicide resistance protein encoded by these nucleotide sequences is set forth in SEQ ID NO:3. The invention also encompasses nucleic acid molecules comprising nucleotide sequences encoding partial-length herbicide resistance proteins, and complements thereof. An "isolated" or "purified" nucleic acid molecule or protein, or biologically active portion thereof, is substantially free of other cellular material, or culture medium when produced by recombinant techniques, or substantially free of chemical precursors or other chemicals when chemically synthesized. Preferably, an "isolated" nucleic acid is free of sequences (preferably protein encoding sequences) that naturally flank the nucleic acid (i.e., sequences located at the 5' and 3' ends of the nucleic acid) in the genomic DNA of the organism from which the nucleic acid is derived. For purposes of the invention, "isolated" when used to refer to nucleic acid molecules excludes isolated chromosomes. For example, in various embodiments, the isolated glyphosate resistance-encoding nucleic acid molecule can contain less than about 5 kb, 4 kb, 3 kb, 2 kb, 1 kb, 0.5 kb, or 0.1 kb of nucleotide sequence that naturally flanks the nucleic acid molecule in genomic DNA of the cell from which the nucleic acid is derived. An herbicide resistance protein that is substantially free of cellular material includes preparations of protein having less than about 30%, 20%, 10%, or 5% (by dry weight) of non-herbicide resistance protein (also referred to herein as a "contaminating protein"). Nucleic acid molecules that are fragments of these herbicide resistance- encoding nucleotide sequences are also encompassed by the present invention. By "fragment" is intended a portion of the nucleotide sequence encoding an herbicide resistance protein. A fragment of a nucleotide sequence may encode a biologically active portion of an herbicide resistance protein, or it may be a fragment that can be used as a hybridization probe or PCR primer using methods disclosed below. Nucleic acid molecules that are fragments of an herbicide resistance nucleotide sequence comprise at least about 15,20, 50, 75,100,200, 300,350,400,450,500, 550, 600, 650, 700, 750, 800, 850, 900, 950, 1000,1050,1100,1150,1200,1250,1300,1350, 1400,1450,1500,1550,1600,1650,1700, 1750,1800,1850,1900,1950 contiguous 5 WO 2006/110188 PCT/US2005/046608 nucleotides, or up to the number of nucleotides present in a full-length herbicide resistance-encoding nucleotide sequence disclosed herein (for example, 2000 nucleotides for SEQ ID NO: 1, and 1257 nucleotides for SEQ ID NO:2). By "contiguous" nucleotides is intended nucleotide residues that are immediately adjacent to one another. Fragments of the nucleotide sequences of the present invention generally will encode protein fragments that retain the biological activity of the full-length glyphosate resistance protein; i.e., herbicide-resistance activity. By "retains herbicide resistance activity" is intended that the fragment will have at least about 30%, at least about 50%, at least about 70%, or at least about 80% of the herbicide resistance activity of the full-length glyphosate resistance proteins disclosed herein as SEQ ID NO:3. Methods for measuring herbicide resistance activity are well known in the art. See, for example, U.S. Patent Nos. 4,535,060, and 5,188,642, each of which are herein incorporated by reference in their entirety. A fragment of an herbicide resistance-encoding nucleotide sequence that encodes a biologically active portion of a protein of the invention will encode at least about 15, 25, 30, 50, 75,100, 125,150,175, 200, 250,300, 350, 400 contiguous amino acids, or up to the total number of ammo acids present in a full-length herbicide resistance protein of the invention (for example, 419 amino acids for the protein of the invention). Herbicide resistance proteins of the present invention are encoded by a nucleotide sequence sufficiently identical to the nucleotide sequence of SEQ ID NO: 1 or 2. The term "sufficiently identical" is intended an amino acid or nucleotide sequence that has at least about 60% or 65% sequence identity, about 70% or 75% sequence identity, about 80% or 85% sequence identity, about 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or 99% sequence identity compared to a reference sequence using one of the alignment programs described herein using standard parameters. One of skill in the art will recognize that these values can be appropriately adjusted to determine corresponding identity of proteins encoded by two nucleotide sequences by taking into account codon degeneracy, amino acid similarity, reading frame positioning, and the like. 6 WO 2006/110188 PCT/US2005/046608 To determine the percent identity of two amino acid sequences or of two nucleic acids, the sequences are aligned for optimal comparison purposes. The percent identity between the two sequences is a function of the number of identical positions shared by the sequences (i.e., percent identity = number of identical positions/total number of positions (e.g., overlapping positions) x 100). In one embodiment, the two sequences are the same length. The percent identity between two sequences can be determined using techniques similar to those described below, with or without allowing gaps. In calculating percent identity, typically exact matches are counted. The determination of percent identity between two sequences can be accomplished using a mathematical algorithm. A non-limiting example of a mathematical algorithm utilized for the comparison of two sequences is the algorithm of Karlin and Altschul (1990) Proc. Natl. Acad. Sci. USA 87:2264-2268, modified as in Karlin and Altschul (1993) Proc. Natl. Acad. Sci. USA 90:5873-5877. Such an algorithm is incorporated into the BLASTN and BLASTX programs of Altschul et al. (1990) J. Mol. Biol. 215:403-410. BLAST nucleotide searches can be performed with the BLASTN program, score = 100, wordlength = 12, to obtain nucleotide sequences homologous to GDC-like nucleic acid molecules of the invention. BLASTprotein searches can be performed with the BLASTX program, score = 50, wordlength = 3, to obtain amino acid sequences homologous to herbicide resistance protein molecules of the invention. To obtain gapped alignments for comparison purposes, Gapped BLAST can be utilized as described in Altschul et al. (1997) Nucleic Acids Res. 25:3389-3402. Alternatively, PSI-Blast can be used to perform an iterated search that detects distant relationships between molecules. See Altschul et al. (1997) supra. When utilizing BLAST, Gapped BLAST, and PSI-Blast programs, the default parameters of the respective programs (e.g., BLASTX and BLASTN) can be used. See www.ncbi.nhn.nih.gov. Another non-limiting example of a mathematical algorithm utilized for the comparison of sequences is the ClustalW algorithm (Higgins et al.(1994) Nucleic Acids Res. 22:4673-4680). ClustalW compares sequences and aligns the entirety of the amino acid or DNA sequence, and thus can provide data about the sequence conservation of the entire amino acid sequence. The ClustalW algorithm is used in several commercially available DNA/amino acid 7 WO 2006/110188 PCT/US2005/046608 analysis software packages, such as the ALIGNX module of the Vector NTI Program Suite (Invitrogen Corporation, Carlsbad, CA). After alignment of amino acid sequences with ClustalW, the percent amino acid identity can be assessed. A non- limiting example of a software program useful for analysis of ClustalW alignments is GeneDoc™. Genedoc™ (Karl Nicholas) allows assessment of amino acid (or DNA) similarity and identity between multiple proteins. Another non-limiting example of a mathematical algorithm utilized for the comparison of sequences is the algorithm of Myers and Miller (1988) CABIOS 4:11-17. Such an algorithm is incorporated into the ALIGN program (version 2.0), which is part of the GCG sequence alignment software package (available from Accelrys, Inc., San Diego, CA). When utilizing the ALIGN program for comparing amino acid sequences, a PAM120 weight residue table, a gap length penalty of 12, and a gap penalty of 4 can be used. '. Unless otherwise stated, GAP Version 10, which uses the algorithm of Needleman and Wunsch (1970) J. Mol Biol 48(3):443-453, will be used to determine sequence identity or similarity using the following parameters: % identity and % similarity for a nucleotide sequence using GAP Weight of 50 and Length Weight of 3, and the nwsgapdna.cmp scoring matrix; % identity or % similarity for an amino acid sequence using GAP weight of 8 and length weight of 2, and the BLOSUM62 scoring. program. Equivalent programs may also be used. By "equivalent program" is intended any sequence comparison program that, for any two sequences in question, generates an alignment having identical nucleotide residue matches and an identical percent sequence identity when compared to the corresponding alignment generated by GAP Version 10. The invention also encompasses variant nucleic acid molecules. "Variants" of the herbicide resistance-encoding nucleotide sequences include those sequences that encode the herbicide resistance protein disclosed herein but that differ conservatively because of the degeneracy of the genetic code, as well as those that are sufficiently identical as discussed above. Naturally occurring allelic variants can be identified with the use of well-known molecular biology techniques, such as polymerase chain reaction (PCR) and hybridization techniques as outlined below. Variant nucleotide sequences also include synthetically derived nucleotide sequences that have been generated, for example, by using site-directed mutagenesis but which still encode the 8 WO 2006/110188 PCT/US2005/046608 herbicide resistance proteins disclosed in the present invention as discussed below. Variant proteins encompassed by the present invention are biologically active, that is they retain the desired biological activity of the native protein, that is, herbicide resistance activity. By "retains herbicide resistance activity" is intended that the variant will have at least about 30%, at least about 50%, at least about 70%, or at least about 80% of the herbicide resistance activity of the native protein. Methods for measuring herbicide resistance activity are well known in the art. See, for example, U.S. Patent Nos. 4,535,060, and 5,188,642, each of which are herein incorporated by reference in their entirety. The skilled artisan will further appreciate that changes can be introduced by mutation into the nucleotide sequences of the invention thereby leading to changes in the amino acid sequence of the encoded herbicide resistance proteins, without altering the biological activity of the proteins. Thus, variant isolated nucleic acid molecules cart be created by introducing one or more nucleotide substitutions, additions, or deletions into the corresponding nucleotide sequence disclosed herein, such that one or more amino acid substitutions, additions or deletions are introduced into the encoded protein. Mutations can be introduced by standard techniques, such as site- directed mutagenesis and PCR mediated mutagenesis. Such variant nucleotide sequences are aiso encompassed by the present invention. For example, conservative amino acid substitutions may be made at one or more predicted, nonessential amino acid residues. A "nonessential" amino acid residue is a residue that can be altered from the wild-type sequence of an herbicide resistance protein without altering the biological activity, whereas an "essential" amino acid residue is required for biological activity. A "conservative amino acid substitution" is one in which the amino acid residue is replaced with an amino acid residue having a similar side chain. Families of amino acid residues having similar side chains have been defined in the art. These families include amino acids with basic side chains (e.g., lysine, arginine, histidine), acidic side chains (e.g., aspartic acid, glutamic acid), uncharged polar side chains (e.g., glycine, asparagine, glutamine, serine, threonine, tyrosine, cysteine), nonpolar side chains (e.g., alanine, valine, leucine, isoleucine, proline, phenylalanine, methionine, tryptophan), beta-branched side chains (e.g., threonine, valine, isoleucine) and aromatic side chains (e.g., 9 WO 2006/110188 PCT/US2005/046608 tyrosine, phenylalanine, tryptophan, histidine). Amino acid substitutions may be made in non-conserved regions that retain function. In general, such substitutions would not be made for conserved amino acid residues, or for amino acid residues residing within a conserved motif, where such residues are essential for protein activity. However, one of skill in the art would understand that functional variants may have minor conserved or non-conserved alterations in the conserved residues. Alternatively, variant nucleotide sequences can be made by introducing mutations randomly along all or part of the coding sequence, such as by saturation mutagenesis, and the resultant mutants can be screened for the ability to confer herbicide resistance activity to identify mutants that retain activity. Following mutagenesis, the encoded protein can be expressed in a cell, and the activity of the protein can be determined using standard assay techniques. Using methods such as PCR, hybridization, and the like corresponding herbicide resistance sequences can be identified, such sequences having substantial identity to the sequences of the invention. See, for example, Sambrook and Russell (2001) Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY) and Innis, et al. (1990) PCR Protocols: A Guide to Methods and Applications (Academic Press, Sl..Louis, MO). In a hybridization method, ail or part of the herbicide resistance nucleotide sequence can be used to screen cDNA or genomic libraries. Methods for construction of such cDNA and genomic libraries are generally known in the art and are disclosed in Sambrook and Russell (2001) supra. The so-called hybridization probes may be genomic DNA fragments, cDNA fragments, RNA fragments, or other oligonucleotides, and may be labeled with a detectable group such as 32P, or any other detectable marker, such as other radioisotopes, a fluorescent compound, an enzyme, or an enzyme co-factor. Probes for hybridization can be made by labeling synthetic oligonucleotides based on the known herbicide resistance-encoding nucleotide sequence(s) disclosed herein. Degenerate primers designed on the basis of conserved nucleotides or amino acid residues in the nucleotide sequence or encoded amino acid sequence can additionally be used. The probe typically comprises a region of nucleotide sequence that hybridizes under stringent conditions to at least about 12, at least about 25, at least about 50, 75,100,125,150,175, 200,250, 300, 350,400, 500, 10 WO 2006/110188 PCT/US2005/046608 600, 700, 800, 900,1000,1200, 1400, 1600, or 1800 consecutive nucleotides of herbicide resistance-encoding nucleotide sequence(s) of the invention or a fragment or variant thereof. Methods for the preparation of probes for hybridization are generally known in the art and are disclosed in Sambrook and Russell (2001) supra, and Sambrook et al. (1989) Molecular Cloning: A Laboratory Manual (2d ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY), both of which are herein incorporated by reference. For example, an entire herbicide resistance sequence disclosed herein, or one or more portions thereof, may be used as a probe capable of specifically hybridizing to corresponding herbicide resistance sequences and messenger KNAs. To achieve specific hybridization under a variety of conditions, such probes include sequences that are unique and are at least about 10 nucleotides in length, and at least about 20 nucleotides in length. Such probes may be used to amplify corresponding herbicide resistance sequences from a chosen organism by PCR. This technique may be used to isolate additional coding sequences from a desired organism or as a diagnostic assay to determine the presence of coding sequences in an organism. Hybridization techniques include hybridization screening of plated DNA libraries (either plaques or colonies; see, for example, Sambrook et al. (1989) Molecular Cloning: A Laboratory Manual (2d ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY). Hybridization of such sequences may be carried out under stringent conditions. By "stringent conditions" or "stringent hybridization conditions" is intended conditions under which a probe will hybridize to its target sequence to a detectably greater degree than to other sequences (e.g., at least 2-fold over background). Stringent conditions are sequence-dependent and will be different in different circumstances. By controlling the stringency of the hybridization and/or washing conditions, target sequences that are 100% complementary to the probe can be identified (homologous probing). Alternatively, stringency conditions can be adjusted to allow some mismatching in sequences so that lower degrees of similarity are detected (heterologous probing). Generally, a probe is less than about 1000 nucleotides in length, or less than about 500 nucleotides in length. Typically, stringent conditions will be those in which the salt concentration is less than about 1.5 M Na ion, typically about 0.01 to 1.0 M Na ion concentration (or 11 WO 2006/110188 PCT/US2005/046608 other salts) at pH 7.0 to 8.3 and the temperature is at least about 30°C for short probes (e.g., 10 to 50 nucleotides) and at least about 60°C for long probes (e.g., greater than 50 nucleotides). Stringent conditions may also be achieved with the addition of destabilizing agents such as formamide. Exemplary low stringency conditions include hybridization with a buffer solution of 30 to 35% formamide, 1 M NaCl, 1% SDS (sodium dodecyl sulfate) at 37°C, and a wash in IX to 2X SSC (20X SSC = 3.0 M NaCl/0.3 M trisodium citrate) at 50 to 55°C. Exemplary moderate stringency conditions include hybridization in 40 to 45% formamide, 1.0 M NaCl, 1% SDS at 37°C, and a wash in 0.5X to IX SSC at 55 to 60°C. Exemplary high stringency conditions include hybridization in 50% formamide, 1 M NaCl, 1% SDS at 37°C, and a wash in 0.1X SSC at 60 to 65°C. Optionally, wash buffers may comprise about 0.1% to about 1% SDS. Duration of hybridization is generally less than about 24 hours, usually about 4 to about 12 hours. Specificity is typically the function of post-hybridization washes, the critical factors being the ionic strength and temperature of the final wash solution. For DNA- DNA hybrids, the Tm can be approximated from the equation of Meinkoth and Wahl (1984) Anal. Biochem. 138:267-284: Tm= 81.5°C +16.6 (log M) + 0.41 (%GC) - 0.61 (% form) - 500/L; where M is the molarity of monovalent cations, %GC is the percentage of guanosine and cytosine nucleotides in the DNA, % form is the percentage of formamide in the hybridization solution, and L is the length of the hybrid in base pairs. The Tm is the temperature (under defined ionic strength and pH) at which 50% of a complementary target sequence hybridizes to a perfectly matched probe. Tm is reduced by about 1°C for each 1% of mismatching; thus, Tm, hybridization, and/or wash conditions can be adjusted to hybridize to sequences of the desired identity. For example, if sequences with ≥90% identity are sought, the Tm can be decreased 10°C. Generally, stringent conditions are selected to be about 5°C lower than the thermal melting point (Tm) for the specific sequence and its complement at a defined ionic strength and pH. However, severely stringent conditions can utilize a hybridization and/or wash at 1,2, 3, or 4°C lower than the thermal melting point (Tm); moderately stringent conditions can utilize a hybridization and/or wash at 6,7, 8, 9, or 10°C lower than the thermal melting point (Tm); low stringency conditions can utilize a hybridization and/or wash at 11, 12,13, 14,15, or 20°C lower than the thermal 12 WO 2006/110188 PCT/US2005/046608 melting point (Tm). Using the equation, hybridization and wash compositions, and desired Tm, those of ordinary skill will understand that variations in the stringency of hybridization and/or wash solutions are inherently described. If the desired degree of mismatching results in a Tm of less than 45 °C (aqueous solution) or 32°C (formamide solution), it is preferred to increase the SSC concentration so that a higher temperature can be used. An extensive guide to the hybridization of nucleic acids is found in Tijssen (1993) Laboratory Techniques in Biochemistry and Molecular Biology— Hybridization with Nucleic Acid Probes, Part I, Chapter 2 (Elsevier, New York); and Ausubel et al, eds. (1995) Current Protocols in Molecular Biology, Chapter 2 (Greene Publishing and Wiley-Interscience, New York). See Sambrook et al, (1989) Molecular Cloning: A Laboratory Manual (2d ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY). Isolated Proteins and Variants and Fragments Thereof Herbicide resistance proteins are also encompassed within the present invention. By "herbicide resistance protein" is intended a protein having the amino acid sequence set forth in SEQ ID NO:3. Fragments, biologically active portions, and variants thereof are also provided, and may be used to practice the methods of the present invention. "Fragments" or "biologically active portions" include polypeptide fragments comprising a portion of an amino acid sequence encoding an herbicide resistance protein as set forth in SEQ ID NO:3 and that retains herbicide resistance activity. A biologically active portion of an herbicide resistance protein can be a polypeptide that is, for example, 10, 25, 50,100 or more amino acids in length. Such biologically active portions can be prepared by recombinant techniques and evaluated for herbicide resistance activity. Methods for measuring herbicide resistance activity are well known in the art. See, for example, U.S. Patent Nos. 4,535,060, and 5,188,642, each of which are herein incorporated by reference in their entirety. As used here, a fragment comprises at least 8 contiguous ammo acids of SEQ ID NO:3. The invention encompasses other fragments, however, such as any fragment in the protein greater than about 10, 20, 30, 50,100,150, 200,250, 300, 350, or 400 amino acids. 13 WO 2006/110188 PCT/US2005/046608 By "variants" is intended proteins or polypeptides having an amino acid sequence that is at least about 60%, 65%, at least about 70%, 75%, at least about 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or 99% identical to the amino acid sequence of SEQ ID NO:3. Variants also include polypeptides encoded by a nucleic acid molecule that hybridizes to the nucleic acid molecule of SEQ ID NOS:1 or 2, or a complement thereof, under stringent conditions. Variants include polypeptides that differ in amino acid sequence due to mutagenesis. Variant proteins encompassed by the present invention are biologically active, that is they continue to possess the desired biological activity of the native protein, that is, retaining herbicide resistance activity. Methods for measuring herbicide resistance activity are well known in the art. See, for example, U.S. Patent Nos. 4,535,060, and 5,188,642, each of which are herein incorporated by reference in their entirety. Bacterial genes, such as the grg8 gene of this invention, quite often possess multiple methionine initiation codons in proximity to the start of the open reading frame. Often, translation initiation at one or more of these, start codons will lead to generation of a functional protein. These start codons can include ATG codons. However, bacteria such as Bacillus sp. also recognize the codon GTG as a start codon, and proteins that initiate translation at GTX codons contain a methionine at theiirst amino acid, furthermore, it is not often determined a priori which of these codons are used naturally in the bacterium. Thus, it is understood that use of one of the alternate methionine codons may lead to generation of variants of grg8 that confer herbicide resistance. These herbicide resistance proteins are encompassed in the present invention and may be used in the methods of the present invention. Antibodies to the polypeptides of the present invention, or to variants or fragments thereof, are also encompassed. Methods for producing antibodies are well known in the art (see, for example, Harlow and Lane (1988) Antibodies: A Laboratory Manual (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY); U.S. Patent No. 4,196,265). Altered or Improved Variants It is recognized that the DNA sequence of grg8 may be altered by various methods, and that these alterations may result in DNA sequences encoding proteins 14 WO 2006/110188 PCT/US2005/046608 with amino acid sequences different than that encoded by grg8. This protein may be altered in various ways including amino acid substitutions, deletions, truncations, and insertions. Methods for such manipulations are generally known in the art. For example, amino acid sequence variants of the GRG8 protein can be prepared by mutations in the DNA. This may also be accomplished by one of several forms of mutagenesis and/or by directed evolution. In some aspects, the changes encoded in the amino acid sequence will not substantially affect the function of the protein. Such variants will possess the desired herbicide resistance activity. However, it is understood that the ability of GRG8 to confer herbicide resistance may be improved by use of such techniques upon the compositions of the present invention. For example, GRG8 may be expressed in host cells that exhibit high rates of base misincorporation during DNA replication, such as XL-1 Red (Stratagene, La Jolla, CA). After propagation in such strains, grg8 DNA can be isolated (for example by preparing plasmid DNA, or by amplifying by PCR and cloning the resulting PCR fragment into a vector) and cultured in non-mutagenic strains. Clones containing mutations in grg8 can be identified by measuring improved resistance to an herbicide such as glyphosate, for example by growing cells in increasing concentrations of glyphosatc and testing for clones that confer tolcerance to increasing concentrations of glyphosate. Alternatively, alterations may be made to the protein sequence of many proteins at the amino or carboxy terminus without substantially affecting activity. These alterations can include insertions, deletions, or alterations introduced by modern molecular methods, such as PCR, including PCR amplifications that alter or extend the protein coding sequence by virtue of inclusion of amino acid encoding sequences in the oligonucleotides utilized in the PCR amplification. Alternatively, the protein sequences added can include entire protein-coding sequences, such as those used commonly in the art to generate protein fusions. Such fusion proteins are often used to (1) increase expression of a protein of interest; (2) introduce a binding domain, enzymatic activity, or epitope to facilitate either protein purification, protein detection, or other experimental uses known in the art; or, (3) target secretion or translation of a protein to a subcellular organelle, such as the periplasmic space of 15 WO 2006/110188 PCT/US2005/046608 gram-negative bacteria, or the endoplasmic reticulum of eukaryotic cells, the latter of which often results in glycosylation of the protein. Variant nucleotide and amino acid sequences of the present invention also encompass sequences derived from mutagenic and recombinogenic procedures such as DNA shuffling. With such a procedure, one or more different herbicide resistance protein coding regions can be used to create a new herbicide resistance protein possessing the desired properties. In this manner, libraries of recombinant polynucleotides are generated from a population of related sequence polynucleotides comprising sequence regions that have substantial sequence identity and can be homologously recombined in vitro or in vivo. For example, using this approach, sequence motifs encoding a domain of interest may be shuffled between the herbicide resistance gene of the invention and other known herbicide resistance genes to obtain a new gene coding for a protein with an improved property of interest, such as an increased glyphosate resistance activity. Strategies for such DNA shuffling are known in the art. See, for example, Stemmer (1994) Proc. Natl. Acad. Sci. USA 91:10747-10751; Stemmer (1994) Nature 370:389-391; Crameri et al. (1997) Nature Biotech. 15:436-438; Moore et al. (1997) J. Mol. Biol 272:336-347; Zhang et al. (1927) Proc. Natl, Acad. Sci. USA 94:451)44509; Crameri et al (1998)Nature 391:288-291; and U.S. Patent Nos. 5,605,793 and 5,837,458. Transformation of Bacterial or Plant Cells Provided herein are novel isolated genes that confer resistance to an herbicide. Also provided is an amino acid sequence of the GRG8 protein. The protein resulting from translation of this gene allows cells to function in the presence of concentrations of an herbicide that are otherwise toxic to cells including plant cells and bacterial cells. In one aspect of the invention, the grg8 gene is useful as a marker to assess transformation of bacterial or plant cells. By engineering grg8 to be (1) expressed from a bacterial promoter known to stimulate transcription in the organism to be tested, (2) properly translated to generate an intact GRG8 peptide, and (3) placing the cells in an otherwise toxic concentration of herbicide, cells that have been transformed with DNA by virtue of their resistance to herbicide can be identified. By "promoter" is intended a nucleic acid sequence that 16 WO 2006/110188 PCT/US2005/046608 functions to direct transcription of a downstream coding sequence. The promoter, together with other transcriptional and translational regulatory nucleic acid sequences, (also termed "control sequences") are necessary for the expression of a DNA sequence of interest. Transformation of bacterial cells is accomplished by one of several techniques known in the art, including but not limited to, electroporation or chemical transformation (See, for example, Ausubel (ed.) (1994) Current Protocols in Molecular Biology (John Wiley and Sons, Inc., Indianapolis, IN)). Markers conferring resistance to toxic substances are useful in identifying transformed cells (having taken up and expressed the test DNA) from non-transformed cells (those not containing or not expressing the test DNA). In one aspect of the invention, the grg8 gene is useful as a marker to assess transformation of bacterial or plant cells. Transformation of plant cells can be accomplished in a similar fashion. By "plant" is intended whole plants, plant organs (e.g., leaves, stems, roots, etc.), seeds, plant cells, propagules, embryos and progeny of the same. Plant cells can be differentiated or undifferentiated (e.g. callus, suspension culture cells, protoplasts, leaf cells, root cells, phloem cells, pollen). "Transgenic plants" or "transformed plants" or "stably transformed" plants, cells or tissues, refer to plants that haye incorporated or integrated exogenous nucleic acid sequences or DNA fragments into the plant ceil. By "stable transformation" is intended that the nucleotide construct introduced into a plant integrates into the genome of the plant and is capable of being inherited by progeny thereof. The grg8 gene of the invention may be modified to obtain or enhance expression in plant cells. The herbicide resistance sequences of the invention may be provided in expression cassettes for expression in the plant of interest. "Plant expression cassette" includes DNA constructs that are capable of resulting in the expression of a protein from an open reading frame in a plant cell. The cassette will include in the 5 '-3' direction of transcription, a transcriptional initiation region (i.e., promoter) operably-linked to a DNA sequence of the invention, and a translational and transcriptional termination region (i.e., termination region) functional in plants. The cassette may additionally contain at least one additional gene to be co- transformed into the organism, such as a selectable marker gene. Alternatively, the 17 WO 2006/110188 PCT/US2005/046608 additional gene(s) can be provided on multiple expression cassettes. Such an expression cassette is provided with a plurality of restriction sites for insertion of the herbicide resistance sequence to be under the transcriptionai regulation of the regulatory regions. The promoter may be native or analogous, or foreign or heterologous, to the plant host and/or to the DNA sequence of the invention. Additionally, the promoter may be the natural sequence or alternatively a synthetic sequence. Where the promoter is "native" or "homologous" to the plant host, it is intended that the promoter is found in the native plant into which the promoter is introduced. Where the promoter is "foreign" or "heterologous" to the DNA sequence of the invention, it is intended that the promoter is not the native or naturally occurring promoter for the operably linked DNA sequence of the invention. "Heterologous" generally refers to the nucleic acid sequences that are not endogenous to the cell or part of the native genome in which they are present, and have been added to the cell by infection, transfection, microinjection, electroporation, microprojection, or the like. By "operably linked" is intended a functional linkage between a promoter and a second sequence, wherein the promoter sequence initiates and mediates transcription of the DNA sequence corresponding to the second sequence, Generally, operably linked means that the nucleic acid sequences being linked are contiguous and, where necessary to join two protein coding regions, contiguous and in the same reading frame. Often, such constructs will also contain 5' and 3' untranslated regions. Such constructs may contain a "signal sequence" or "leader sequence" to facilitate co- translational or post-translational transport of the peptide of interest to certain intracellular structures such as the chloroplast (or other plastid), endoplasmic reticulum, or Golgi apparatus, or to be secreted. For example, the gene can be engineered to contain a signal peptide to facilitate transfer of the peptide to the endoplasmic reticulum. By "signal sequence" is intended a sequence that is known or suspected to result in cotranslational or post-translational peptide transport across the cell membrane. In eukaryotes, this transport typically involves secretion into the Golgi apparatus, with some resulting glycosylation. By "leader sequence" is intended any sequence that when translated, results in an amino acid sequence sufficient to 18 WO 2006/110188 PCT/US2005/046608 trigger co-translational transport of the peptide chain to a sub-cellular organelle. Thus, this includes leader sequences targeting transport and/or glycosylation by passage into the endoplasmic reticulum, passage to vacuoles, plastids including chloroplasts, mitochondria, and the like. The plant expression cassette can also be engineered to contain an intron, such that mRNA processing of the intron is required for expression. By "3' untranslated region" is intended a nucleotide sequence located downstream of a coding sequence. Polyadenylation signal sequences and other sequences encoding regulatory signals capable of affecting the addition of polyadenylic acid tracts to the 3' end of the mRNA precursor are 3' untranslated regions. By "5' untranslated region" is intended a nucleotide sequence located upstream of a coding sequence. Other upstream or downstream untranslated elements include enhancers. Enhancers are nucleotide sequences that act to increase the expression of a promoter region. Enhancers are well known in the art and include, but are not limited to, the SV40 enhancer region and the 35S enhancer element. The termination region may be native with the transcriptional initiation region, may be native with the herbicide resistance sequence of the present invention, or may be derived from another source. Convenient termination regions are available from the Ti-plasmid of A. tumefaciens, such as the octopine synthase and nopaline synthase termination regions. See also Guerineau et al. (1991) Mol. Gen. Genet. 262:141-144; Proudfoot (1991) Cell 64:611-674; Sanfacon et al. (1991) Genes Dev. 5:141-149; Mogen et al. (1990) Plant Cell 2:1261-1272; Munroe et al. (1990) Gene 91:151-158; Ballas et al. (1989) Nucleic Acids Res. 17:7891-7903; and Joshi et al. (1987) Nucleic AcidRes. 15:9627-9639. Where appropriate, the gene(s) may be optimized for increased expression in the transformed host cell. That is, the genes can be synthesized using host cell- preferred codons for improved expression, or may be synthesized using codons at a host-preferred codon usage frequency. Generally, the GC content of the gene will be increased. See, for example, Campbell and Gowri (1990) Plant Physiol. 92:1-11 for a discussion of host-preferred codon usage. Methods are known in the art for synthesizing host-preferred genes. See, for example, U.S. Patent Nos. 6,320,100; 6,075,185; 5,380,831; and 5,436,391, U.S. Published Application Nos. 20040005600 19 WO 2006/110188 PCT/US2005/046608 and 20010003849, and Murray et al. (1989) Nucleic Acids Res. 17:477-498, herein incorporated by reference. In one embodiment, the nucleic acids of interest are targeted to the chioropiast for expression. In this manner, where the nucleic acid of interest is not directly inserted into the chioropiast, the expression cassette will additionally contain a nucleic acid encoding a transit peptide to direct the gene product of interest to the chloroplasts. Such transit peptides are known in the art. See, for example, Von Heijne et al. (1991) Plant Mol. Biol. Rep. 9:104-126; Clark et al. (1989) J. Biol. Chem. 264:17544-17550; Della-Cioppa et al. (1987) Plant Physiol. 84:965-968; Romer et al. (1993) Biochem. Biophys. Res. Commun. 196:1414-1421; and Shah et al. (1986) Science 233:478-481. The nucleic acids of interest to be targeted to the chioropiast may be optimized for expression in the chioropiast to account for differences in codon usage between the plant nucleus and this organclle. In this manner, the nucleic acids of interest may be synthesized using chloroplast-preferred codons. See, for example, U.S. Patent No. 5,380,831, herein incorporated by reference. Typically this "plant expression cassette" will be inserted into a "plant transformation vector." By "transformation vector" is intendeds DNA molecule that is necessary for efficient transformation of a ceil. Such a molecule may consist of one or more expression cassettes, and may be organized into more than one "vector" DNA molecule. For example, binary vectors are plant transformation vectors that utilize two non-contiguous DNA vectors to encode all requisite cis- and trans-acting functions for transformation of plant cells (Hellens and Mullineaux (2000) Trends in Plant Science 5:446-451). "Vector" refers to a nucleic acid construct designed for transfer between different host cells. "Expression vector" refers to a vector that has the ability to incorporate, integrate and express heterologous DNA sequences or fragments in a foreign cell. This plant transfonnation vector may be comprised of one or more DNA vectors needed for achieving plant transformation. For example, it is a common practice in the art to utilize plant transformation vectors that are comprised of more than one contiguous DNA segment. These vectors are often referred to in the art as "binary vectors." Binary vectors as well as vectors with helper plasmids are most 20 WO 2006/110188 PCT/US2005/046608 often used for Agrobacterium-mediated transformation, where the size and complexity of DNA segments needed to achieve efficient transformation is quite large, and it is advantageous to separate functions onto separate DNA molecules. Binary vectors typically contain a plasmid vector that contains the cis-acting sequences required for T-DNA transfer (such as left border and right border), a selectable marker that is engineered to be capable of expression in a plant cell, and a "gene of interest" (a gene engineered to be capable of expression in a plant cell for which generation of transgenic plants is desired). Also present on this plasmid vector are sequences required for bacterial replication. The cis-acting sequences are arranged in a fashion to allow efficient transfer into plant cells and expression therein. For example, the selectable marker gene and the gene of interest are located between the left and right borders. Often a second plasmid vector contains the trans-acting factors that mediate T-DNA transfer from Agrobacterium to plant cells. This plasmid often contains the virulence functions (Vir genes) that allow infection of plant cells by Agrobacterium, and transfer of DNA by cleavage at border sequences and vir- mediated DNA transfer, as in understood in the art (Hellens and Mullineaux (2000) Trends in Plant Science, 5:446-451). Several types of Agrobacterium strains (e.g. LBA4404, GV3101, EHAlOl, EHA105, etc.) can be used for plant transformation The second plasmid vector is not necessary for transforming the plants by other methods such as microprojection, microinjection, electroporation, polyethylene glycol, etc. Plant Transformation Methods of the invention involve introducing a nucleotide construct into a plant. By "introducing" is intended to present to the plant the nucleotide construct in such a manner that the construct gains access to the interior of a cell of the plant. The methods of the invention do not require that a particular method for introducing a nucleotide construct to a plant is used, only that the nucleotide construct gains access to the interior of at least one cell of the plant. Methods for introducing nucleotide constructs into plants are known in the art including, but not limited to, stable transformation methods, transient transformation methods, and virus-mediated methods. 21 WO 2006/110188 PCT/US2005/046608 In general, plant transformation methods involve transferring heterologous DNA into target plant cells (e.g. immature or mature embryos, suspension cultures, undifferentiated cailus, protoplasts, etc.), followed by applying a maximum threshold level of appropriate selection (depending on the selectable marker gene and in this case "glyphosate") to recover the transformed plant cells from a group of untransformed cell mass. Explants are typically transferred to a fresh supply of the same medium and cultured routinely. Subsequently, the transformed cells are differentiated into shoots after placing on regeneration medium supplemented with a maximum threshold level of selecting agent (e.g. "glyphosate"). The shoots are then transferred to a selective rooting medium for recovering rooted shoot or plantlet. The transgenic plantlet then grow into mature plants and produce fertile seeds (e.g. Hiei et al. (1994) The Plant Journal 6:271-282; Ishida et al. (1996) Nature Biotechnology 14:745-750). Explants are typically transferred to a fresh supply of the same medium and cultured routinely. A general description of the techniques and methods for generating transgenic plants are found in Ayres and Park (1994) Critical Reviews in Plant Science 13:219-239 and Bomanineni and Jauhar (1997) Maydica 42:107-120. Since the transformed material contains many cells; both transformed and non- transformed cells are present in any piece ofsubjected target callusor tissue or group of cells. The ability to kill non-transformed cells and allow transformed cells to proliferate results in transformed plant cultures. Often, the ability to remove non- transformed cells is a limitation to rapid recovery of transformed plant cells and successful generation of transgenic plants. Molecular and biochemical methods can be used to confirm the presence of the integrated heterologous gene of interest in the genome of transgenic plant. Generation of transgenic plants may be performed by one of several methods, including, but not limited to, introduction of heterologous DNA by Agrobacterium into plant cells (Agrobacterium-mediated transformation), bombardment of plant cells with heterologous foreign DNA adhered to particles, and various other non-particle direct-mediated methods (e.g. Hiei et al. (1994) The Plant Journal 6:271-282; Ishida et al. (1996) Nature Biotechnology 14:745-750; Ayres and Park (1994) Critical Reviews in Plant Science 13:219-239; Bommineni and Jauhar (1997) Maydica 42:107-120) to transfer DNA. 22 WO 2006/110188 PCT/US2005/046608 Methods for transformation of chloroplasts are known in the art. See, for example, Svab et al. (1990) Proc. Natl. Acad. Sci. USA 87:8526-8530; Svab and Maliga (1993) Proc. Natl. Acad. Sci. USA 90:913-917; Svab and Maliga (1993) EMBO J. 12:601-606. The method relies on particle gun delivery of DNA containing a selectable marker and targeting of the DNA to the plastid genome through homologous recombination. Additionally, plastid transformation can be accomplished by transactivation of a silent plastid-borne transgene by tissue-preferred expression of a nuclear-encoded and plastid-directed RNA polymerase. Such a system has been reported in McBride et al. (1994) Proc. Natl. Acad. Sci. USA 91:7301-7305. The cells that have been transformed may be grown into plants in accordance with conventional ways. See, for example, McCormick et al. (1986) Plant Cell Reports 5:81-84. These plants may then be grown, and either pollinated with the same transformed strain or different strains, and the resulting hybrid having constitutive expression of the desired phenotypic characteristic identified. Two or more generations may be grown to ensure that expression of the desired phenotypic characteristic is stably maintained and inherited and then seeds harvested to ensure expression of the desired phenotypic characteristic has been a chieved. In this manner, the present invention provides transformed seed (also referred to as "transgenic seed") having a nucleotide construct of the invention, for example, an expression cassette of the invention, stably incorporated into their genome. Plants The present invention may be used for transformation of any plant species, including, but not limited to, monocots and dicots. Examples of plants of interest include, but are not limited to, corn (maize), sorghum, wheat, sunflower, tomato, crucifers, peppers, potato, cotton, rice, soybean, sugarbeet, sugarcane, tobacco, barley, and oilseed rape, Brassica sp., alfalfa, rye, millet, safflower, peanuts, sweet potato, cassava, coffee, coconut, pineapple, citrus trees, cocoa, tea, banana, avocado, fig, guava, mango, olive, papaya, cashew, macadamia, almond, oats, vegetables, ornamentals, and conifers. 23 WO 2006/110188 PCT/US2005/046608 Vegetables include, but are not limited to, tomatoes, lettuce, green beans, lima beans, peas, and members of the genus Curcumis such as cucumber, cantaloupe, and musk melon. Ornamentals include, but are not limited to, azalea, hydrangea, hibiscus, roses, tulips, daffodils, petunias, carnation, poinsettia, and chrysanthemum. Preferably, plants of the present invention are crop plants (for example, maize, sorghum, wheat, sunflower, tomato, crucifers, peppers, potato, cotton, rice, soybean, sugarbeet, sugarcane, tobacco, barley, oilseed rape, etc.). This invention is particularly suitable for any member of the monocot plant family including, but not limited to, maize, rice, barley, oats, wheat, sorghum, rye, sugarcane, pineapple, yams, onion, banana, coconut, and dates. Evaluation of Plant Transformation Following introduction of heterologous foreign DNA into plant cells, the transformation or integration of the heterologous gene in the plant genome is confirmed by various methods such as analysis of nucleic acids, proteins and metabolites associated with the integrated gene. PCR analysis is a rapid method to screen transformed cells, tissue or shoots for the presence of incorporated gene at the earlier slage before transplanting into the soil (Sambrook and Russeli (2001) Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY)). PCR is carried out using oligonucleotide primers specific to the gene of interest or Agrobacterium vector background, etc. Plant transformation may be confirmed by Southern blot analysis of genomic DNA (Sambrook and Russell (2001) supra). In general, total DNA is extracted from the transformant, digested with appropriate restriction enzymes, fractionated in an agarose gel and transferred to a nitrocellulose or nylon membrane. The membrane or "blot" can then be probed with, for example, radiolabeled 32P target DNA fragment to confirm the integration of the introduced gene in the plant genome according to standard techniques (Sambrook and Russell, 2001, supra). In Northern analysis, RNA is isolated from specific tissues of transformant, fractionated in a formaldehyde agarose gel, and blotted onto a nylon filter according to standard procedures that are routinely used in the art (Sambrook and Russell (2001) 24 WO 2006/110188 PCT/US2005/046608 supra). Expression of RNA encoded by the grg8 is then tested by hybridizing the filter to a radioactive probe derived from a GDC by methods known in the art (Sambrook and Russell (2001) supra) Western blot and biochemical assays and the like may be carried out on the transgenic plants to determine the presence of protein encoded by the herbicide resistance gene by standard procedures (Sambrook and Russell (2001) supra) using antibodies that bind to one or more epitopes present on the herbicide resistance protein. The following examples are offered by way of illustration and not by way of limitation. EXPERIMENTAL Example 1: Isolation of ATX4145 ATX4145 was isolated by plating samples of soil on Enriched Minimal Media (EMM) containing glyphosate as the sole source of phosphorus. Since EMM contains no aromatic amino acids, a strain must be resistant to glyphosate in order to grow on this media. Two grams of soil were suspended in approximately 30 ml of water, and sonicated for 30 seconds in a sonicating water bath. The sample was vortexed for 5 seconds and permitted to settle for 60 seconds. This process was repeated 3 times. 100 ml of this suspension was added to 3 ml of EMM supplemented with 4 mM glyphosate (pH 6.0). EMM contains (per 900 mls): 10 g sucrose, 2 g NaNO3, 1.0 ml 0.8 M MgSO4,1.0 ml 0.1 M CaCl2,1.0 ml Trace Elements Solution (In 100 ml of l000x solution: 0.1 g FeSO4 7H2O,0.5 mg CuSO4-5H2O,1.0 mg H3BO3,1.0 mg MnSO4-5H2O,7.0 mg ZnSO4-7H20,1.0 mg MoO3,4.0 g KC1). The culture was shaken on a tissue culture roller drum for sixteen days at 21°C and then 100 ml was used to inoculate 3 ml of fresh EMM containing 4 mM glyphosate as the only phosphorus source. After five days, 100 ml was used to inoculate another fresh 3 ml culture. After sufficient growth, the culture was plated onto solid media by streaking a 1 ml loop onto the surface of agar plate containing EMM agar containing 5 mM glyphosate as the sole phosphorus source and stored at 21°C. The culture was then replated for isolation. One particular strain, designated ATX4145, was selected due 25 WO 2006/110188 PCT/US2005/046608 to its ability to grow in the presence of high glyphosate concentrations. On Luria Bertani (LB) agar, colonies are white, circular, pinsize to 1 mm and stain Gram negative. Example 2. Preparation and Screening of Cosmid Libraries Total DNA was extracted from a culture of ATX4145 using methods commonly known in the art. The DNA was partially digested with restriction enzyme Sau3AI and ligated with SuperCos (Stratagene) vector fragment according to the manufacturer's directions. Ligation products were packaged into phage particles using GigaPack III XL packaging extract (Stratagene), transfected into E. coli cells, and plated on LB Agar containing 50 mg/ml kanamycin to select for colonies containing cosmids. Approximately 1100 colonies were picked for screening. Colonies were grown in rich liquid medium containing 50 mg/ml kanamycin, then pinned onto M63 agar medium containing 50 mg/rnl kanamycin and 7 mM glyphosate. M63 agar medium contains 100 mM KH2PO4, 15 mM (NH4SO4, 50 mM CaCl2, 1 mM FeSO4, 50 mM MgCl2, 55 mM glucose, 25 mg/liter L-proline, 10 mg/liter thiamine HC1, sufficient NaOH to adjust the pH to 7.0, and 15 g/liter agar. Several colonies which grewin the presence of 7 mM glyphosate were identified. Cosmid DNA was prepared from each of these colonies and re-transformed into E. coli XL1 Blue MRF cells. In each case cells retransformed with cosmid DNA grew on M63 medium in the presence of 5 mM glyphosate while cells containing empty SuperCos vector did not. One cosmid, designated 3-M5, was selected for further characterization. This cosmid was later renamed pAX298. Example 3. Identification of grg8 in Cosmid pAX298 To identify the gene(s) responsible for the glyphosate-resistance shown by cosmid pAX298, DNA from this clone was mutagenized with transposable elements. In this method, one identifies clones that have suffered transposon insertions, and have lost the ability to confer glyphosate resistance. The location of the transposon insertions identifies the open reading frame responsible for the glyphosate resistance phenotype. 26 WO 2006/110188 PCT/US2005/046608 Cosmid pAX298 was subjected to in vitro transposon mutagenesis using an EZ::TN Insertion Kit (Epicentre, Madison, WT) and the manufacturer's protocol. This process randomly inserts a transposon fragment into the cosmid DNA and thus randomly disrupts the function of genes in the cosmid. This particular transposon contains a gene encoding resistance to trimethoprim, so transposon insertion clones may be selected by the ability to grow in the presence of that antibiotic. The locations of the transposon insertions may be determined by restriction fragment mapping or by sequencing with primers which anneal in the transposon. Transposon insertion clones of pAX298 were plated on M63 medium containing glyphosate. Three clones were found which had lost the ability to grow in the presence of glyphosate, indicating that the transposon had disrupted the gene responsible for resistance. The DNA sequence was determined for the region of pAX298 containing the transposon insertions using sequencing methods well known in the art and is presented below. An open reading frame (ORF, bases 296 through 1555 of SEQ ID NO: 1) was identified. Analysis of sequence data from four transposon insertion picks that had lost resistance to glyphosate revealed that all four insertions were within the ORF. This indicates that the ORF encodes the resistance conferred by the cosmid. Example 4. Homology of GRGS with Other Proteins The deduced amino acid sequence of this ORF has homology to EPSP synthase enzymes, indicating that the ORF encodes an EPSP synthase. Cosmid pAX298 was transformed into E. coli aroA-, a strain in which the native aroA gene, encoding EPSP synthase, has been deleted. This strain cannot grow on M63 medium because it requires exogenously supplied aromatic amino acids. The presence of cosmid pAX298 complemented the aroA- phenotype, that is, it allowed the strain to grow on M63 medium without exogenously supplied aromatic amino acids. This is further evidence that the cosmid contains an EPSP synthase gene. This gene was named grg8. Examination of the deduced amino acid sequence (SEQ ID NO:3) revealed that it does not contain the four domains typical of Class II EPSP synthase enzymes. Thus it is a novel, non-Class II, glyphosate-resistant EPSP synthase. 27 WO 2006/110188 PCT/US2005/046608 Example 5. Engineering of grg8 for Expression of GRG8 Protein in E. coli The grg8 open reading frame (ORF) was amplified by PCR, cloned into the plasmid vector pCR-Blunt-II from Invitrogen, and transformed into E. coli strain DH5a. Plasmid DNA was prepared and the presence and orientation of the inserts were determined by restriction digest. One clone contained the ORF in the forward orientation with respect to the lac promoter in the vector. This plasmid was named pAX299. The insert was sequenced and the plasmid was tested for the ability to confer resistance to glyphosate. Plasmid pAX299 containing the grg8 ORF was deposited at the Agricultural Research Service Culture Collection (NRRL) on December 21, 2004, and assigned Accession No. NRRL B-30804. Example 6. grg8 Confers Resistance to High Levels of Glyphosate pAX299 was tested for the ability to grow on M63 medium in the presence of glyphosate using cells containing empty vector as a control. The plasmid pAX296 in host strain DH5a was used as a negative control. This plasmid contains a fragment of tobacco genomic DNA cloned into the vector pCR-Blunt-II. The results are summarized in Table 1. Starter cultures of the two strains were grown in M63 broth with 50 mg/ml kanamycin to maintain the plasmid. The starter cultures were diluted to approximately equal cell densities, as determined by measuring OD600, then diluted 1 to 200 into 3 ml of M63 broth containing 0 to 200 mM glyphosate. Triplicate 3 ml cultures of each strain in each concentration were grown. Cultures were grown at 37°C with constant shaking. After about 46 hours, 0.3 ml aliquots were withdrawn and the OD600 was measured. The results are presented in Table 1. Values represent means + standard deviations. These results demonstrate that GRG8 confers resistance to high levels of glyphosate. 28 WO 2006/110188 PCT/US2005/046608 Table 1. Glyphosate resistance of pAX299 containing grg8 Glyphosateconcentration (mM) Negativecontrol 0 1.18 + 0.029 1.09 ±0.024 10 1.15 ±0.018 0.04 + 0.0008 20 1.10 + 0.043 0.04 + 0.0004 50 1.20+ 0.037 0.04 + 0.0004 100 1.31+0.024 0.04 ± 0.0005 200 0.05 + 0.004 0.04 + 0.0004 Example 7. Purification of GRG8 Expressed as a 6xHis-tagged Protein in E. coli The grg8 coding region was amplified by PCR using PfuUltra™ DNA polymerase (Stratagene). Oligonucleotides used to prime PCR are designed to introduce restriction enzyme recognition sites near the 5' and 3' ends of the resulting PCR product. The resulting PCR product is digested with Sal I. The digested product is cloned into the 6xHis-tag expression vector pRSFlb (Novagen), prepared by digestion with Sal I. The resulting clone contains GRG8 in the same translational reading frame as, and immediately C-terminal to, the 6xIIis tag. General strategies for generating such clones, and for expressing proteins containing 6xHis-tag are well known in the art. The ability of this clone to confer glyphosate resistance is confirmed by plating cells onto M63 media containing 5 mM glyphosate. The ability the clone containing grgS to grow at this concentration of glyphosate is determined. The level of expression of GRG8 protein may be determined on an SDS-PAGE protein gel. GRG8 protein can be isolated by purification of the induced GRG8 protein by chromatography on, for example, Ni-NTA Superflow Resin (Qiagcn), as per manufacturer's instructions. Example 8. Mutagenesis of grg8 and isolation of functional variants The grg8 open reading frame was mutagenized using PCR-based mutagenesis as known in the art. Plasmid pAX700, containing grg8, was amplified using the Genemorph® mutagenesis kit (Stratagene) using varying amounts of input DNA. The resulting PCR products were purified and digested with Bam HI and Hind III, repurified, and ligated into a modified pRSFlb vector (Novagen). The resulting libraries were transformed into E. coli, picked into 384 well plates, and grown to 29 WO 2006/110188 PCT/US2005/046608 saturation at 37°C. The resulting 384 stock plates were stamped onto minimal media (M63 plus) supplemented with kanamycin, and with varying concentrations of giyphosate. Mutagenized clones that conferred resistance to 50 mM glyphosate (shown in Table 2) were selected. For a subset of these clones, DNA was prepared, and the DNA sequence of the grg8 variant was determined. Table 2. Growth of E. coli expressing grg8 variants in the presence of giyphosate Mutation Original Name Growth on 50mM giyphosate Vector control - - grg8 grg8 +++ grg8m1 C22 +++ grg8m2 N15 +++ grg8m3 N24 +++ grg8m4 Al +++ grg8m5 B2 +++ grg8m6 B7 +++ grg8m7 B11 +++ grg8m8 C11 +++ grg8m9 E3 +++ grg8m10 F4 +++ Example 9. Engineering grg8 for Plant Transformation The grg8 open reading frame (ORF) is amplified by polymerase chain reactions from a full-length cDNA template. HindIII restriction sites are added to each end of the ORF during PCR. Additionally, the nucleotide sequence ACC is added immediately 5' to the start codon of the gene to increase translational efficiency (Kozak (1987) 15:8125-8148; Joshi (1987) Nucleic Acids Research 15:6643-6653). The PCR product is cloned and sequenced, using techniques well known in the art, to ensure that no mutations are introduced during PCR. The plasmid containing the grg8 PCR product is digested with, for example, Hind III, and the fragment containing the intact ORF is isolated. In this example, the fragment is cloned into the Hind III site of a plasmid such as pAX200, a plant expression vector containing the rice actin promoter (McElroy et al. (1991) Molec. Gen. Genet. 231:150-160) and the PinII terminator (An et al. (1989) The Plant Cell 1:115-122). The promoter - gene - terminator fragment from this intermediate 30 WO 2006/110188 PCT/US2005/046608 plasmid is then subcloned into a plasmid such as pSB 11 (Japan Tobacco, Inc.) to form a final plasmid, referred to herein as pSBHGRG8. pSBHGRG8 is organized such that the DNA fragment containing the promoter - grg8 — terminator construct may be excised by double digestion with appropriate restriction enzymes and also used for transformation into plants by, for example, aerosol beam injection. The structure of pSBl 1GRG8 is verified by restriction digests and gel electrophoresis and by sequencing across the various cloning junctions. The plasmid is mobilized into Agrobacterium tumefaciens strain LBA4404 which also harbors the plasmid pSBl (Japan Tobacco, Inc.), using triparental mating procedures well known in the art, and plating on media containing spectinomycin. Plasmid pSBl 1GRG8 carries antibiotic resistance but is a narrow host range plasmid and cannot replicate in Agrobacterium. Antibiotic-resistant colonies arise when pSBl 1GRG8 integrates into the broad host range plasmid, such as pSBl, through homologous recombination. The resulting cointegrate product is verified by Southern hybridization. The Agrobacterium strain harboring the cointegrate can then be used to transform maize, for example by the Purelntro method (Japan Tobacco). Example 10. Transformation of grs8 into Plant Cells Maize ears are best collected 8-12 days after pollination. Embryos are isolated from the ears, and embryos 0.8-1.5 mm in size are preferred for use in transformation. Embryos are plated scutellum side-up on a suitable incubation media, such as DN62A5S media (3.98 g/L N6 Salts; 1 mL/L (of l000x Stock) N6 Vitamins; 800 mg/L L-Asparagine; 100 mg/L Myo-inositol; 1.4 g/L L-Proline; 100 mg/L casamino acids; 50 g/L sucrose; 1 mL/L (of 1 mg/mL Stock) 2,4-D). However, media and salts other than DN62A5S are suitable and are known in the art. Embryos are incubated overnight at 25°C in the dark. However, it is not necessary per se to incubate the embryos overnight. The resulting explants are transferred to mesh squares (30-40 per plate), transferred onto osmotic media for about 30-45 minutes, then transferred to a beaming plate (see, for example, PCT Publication No. WO/0138514 and U.S. Patent No. 5,240,842). 31 WO 2006/110188 PCT/US2005/046608 DNA constructs designed to express GRG8 in plant cells are accelerated into plant tissue using an aerosol beam accelerator, using conditions essentially as described in PCT Publication No. WO/0138514. After beaming, embryos are incubated for about 30 min on osmotic media, and placed onto incubation media overnight at 25°C in the dark. To avoid unduly damaging beamed explants, they are incubated for at least 24 hours prior to transfer to recovery media. Embryos are then spread onto recovery period media, for about 5 days, 25°C in the dark, then transferred to a selection media, Explants are incubated in selection media for up to eight weeks, depending on the nature and characteristics of the particular selection utilized. After the selection period, the resulting callus is transferred to embryo maturation media, until the formation of mature somatic embryos is observed. The resulting mature somatic embryos are then placed under low light, and the process of regeneration is initiated by methods known in the art. The resulting shoots are allowed to root on rooting media, and the resulting plants are transferred to nursery pots and propagated as transgenic plants. Materials Components per liter source Chu'sN6 BasalSalt Mixture(Prod. No. C416) 3.98 g/L Phytotechnology Labs Chu'sN6VitaminSolution (Prod.No. C 149) l mL/L (of l000x Stock) Phytotechnology Labs L-Asparagine 800 mg/L Phytotechnology Labs Myo-inositol 100 mg/L Sigma L-Proline 1.4 g/L Phytotechnology Labs Casamino acids 100 mg/L Fisher Scientific Sucrose 50 g/L Phytotechnology Labs 2,4-D (Prod. No.D-7299) 1 mL/L (of 1 mg/mL Stock) Sigma DN62A5S Media Adjust the pH of the solution to pH 5.8 with IN KOH/1N KC1, add Gelrite (Sigma) to 3 g/L, and autoclave. After cooling to 50°C, add 2 ml/L of a 5 mg/ml stock solution of Silver Nitrate (Phytotechnology Labs). Recipe yields about 20 plates. 32 WO 2006/110188 PCT/US2005/046608 Example 11. Transformation of grg8 into Maize Plant Cells by Azrobacterium- Mediated Transformation Ears are best collected 8-12 days after pollination. Embryos are isolated from the ears, and embryos 0.8-1.5 mm in size are preferred to be used for transformation. Embryos are plated scutellum side-up on a suitable incubation media, and incubated overnight at 25°C in the dark. However, it is not necessary per se to incubate the embryos overnight. Embryos are contacted with an Agrobacterium strain containing the appropriate vectors for Ti plasmid mediated transfer for about 5-10 min, and then plated onto co-cultivation media for about 3 days (25°C in the dark). After co- cultivation, explants are transferred to recovery period media for about five days (at 25°C in the dark). Explants are incubated in selection media for up to eight weeks, depending on the nature and characteristics of the particular selection utilized. After the selection period, the resulting callus is transferred to embryo maturation media, until the formation of mature somatic embryos is observed. The resulting mature somatic embryos are then placed under low light, and the process of regeneration is initiated as known in the art. The resulting shoots are allowed to root on rooting media, and the resulting plants are transferred to nursery pots and propagated as transgenic plants. All publications and patent applications mentioned in the specification are indicative of the level of skill of those skilled in the art to which this invention pertains. All publications and patent applications are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference. Although the foregoing invention has been described in some detail by way of illustration and example for purposes of clarity of understanding, it will be obvious that certain changes and modifications may be practiced within the scope of the appended claims. 33 WO 2006/110188 PCT/US2005/046608 WE CLAIM: 1. A recombinant nucleic acid molecule encoding a 5-enolpyruvylshikimate-3-phosphate synthase enzyme selected from the group consisting of: a) a nucleic acid molecule comprising the nucleotide sequence of SEQ ID NO: 1 or 2, or a complement thereof; b) a nucleic acid molecule comprising a nucleotide sequence having at least 95% sequence identity to the nucleotide sequence of SEQ ID NO: 1 or 2, or a complement thereof, wherein said nucleotide sequence encodes a polypeptide having herbicide resistance activity; c) the herbicide resistance nucleotide sequence of the DNA insert of the plasmid deposited as Accession No. NRRL B-30804, or a complement thereof; d) a nucleic acid molecule which encodes a polypeptide comprising the amino acid sequence of SEQ ID NO:3; and, e) a nucleic acid molecule comprising a nucleotide sequence encoding a polypeptide having at least 95% amino acid sequence identity to the amino acid sequence of SEQ ID NO:3, wherein said polypeptide has herbicide resistance activity. 2. The recombinant nucleic acid molecule as claimed in claim 1, wherein said nucleotide sequence is a synthetic sequence that has been designed for expression in a plant. 3. The recombinant nucleic acid molecule as claimed in claim 1, wherein said nucleic acid molecule is operably linked to a promoter that drives expression of said nucleic acid molecule in a plant cell. 4. A vector comprising the nucleic acid molecule as claimed in claim 1, 2, or 3. 5. The vector as claimed in claim 4, further comprising a nucleic acid molecule encoding a heterologous polypeptide. 6. A host cell that contains the vector as claimed in claim 4, wherein said host cell is a bacterial host cell. 7. A recombinant polypeptide selected from the group consisting of: a) a polypeptide comprising the amino acid sequence of SEQ ID NO:3; b) a polypeptide encoded by the nucleotide sequence of SEQ ID NO: 1 or 2; c) a polypeptide comprising an amino acid sequence having at least 95% sequence identity to the amino acid sequence of SEQ ID NO:3, wherein said polypeptide has herbicide resistance activity; d) a polypeptide that is encoded by a nucleotide sequence that is at least 95% identical to the nucleotide sequence of SEQ ID NO: 1 or 2, wherein said polypeptide has herbicide resistance activity; and, e) a polypeptide that is encoded by the herbicide resistance nucleotide sequence of the DNA insert of the plasmid deposited as Accession No. NRRL B-30804. 8. The polypeptide as claimed in claim 7 further comprising a heterologous amino acid sequence. 9. The polypeptide as claimed in claim 8, wherein said heterologous amino acid sequence further comprises one or more of the following: a) An aspartic acid substituted for a glycine at amino acid 4 of SEQ ID NO:3; b) A serine substituted for a proline at amino acid 12 of SEQ ID NO:3; c) An alanine substituted for the threonine residue at amino acid 47 of SEQ ID NO:3; d) An aspartic acid substituted for a glycine at amino acid 66 of SEQ ID NO:3; e) A methionine substituted for a threonine at amino acid 68 of SEQ ID NO:3; f) A tyrosine substituted for the aspartic acid residue at amino acid 73 of SEQ ID NO:3; g) A methionine substituted for the threonine residue at amino acid 76 of SEQ ID NO:3; h) A cysteine substituted for the glycine residue at amino acid 81 of SEQ ID NO:3; i) A leucine substituted for the proline residue at amino acid 87 of SEQ ID NO:3; j) A valine substituted for the alanine residue at amino acid 89 of SEQ ID NO:3; k) A leucine substituted for the proline residue at amino acid 127 of SEQ ID NO:3; 1) A glutamic acid substituted for an aspartic acid residue at amino acid 133 of SEQ ID NO:3; m) An aspartic acid substituted for a glycine residue at amino acid 139 of SEQ ID NO:3; n) A cysteine substituted for a glycine residue to amino acid 157 of SEQ ID NO:3; o) A serine substituted for a glycine residue at amino acid 169 of SEQ ID NO:3; p) A threonine substituted for an alanine residue at amino acid 188 of SEQ ID NO:3; q) A phenylalanine substituted for a leucine residue at amino acid 194 of SEQ ID NO:3; r) A serine substituted for a glycine residue at amino acid 195 of SEQ ID NO:3; s) A tyrosine substituted for an aspartic acid residue at amino acid 205 of SEQ ID NO:3; t) A valine substituted for an alanine residue at amino acid 209 of SEQ ID NO:3; u) A threonine substituted for an alanine residue at amino acid 225 of SEQ ID NO:3; v) A valine substituted for an alanine residue at amino acid 235 of SEQ ID NO:3; w) An alanine substituted for a valine residue at amino acid 239 of SEQ ID NO:3; x)A threonine substituted for a lysine residue at amino acid 260 of SEQ ID NO:3; y) A methionine substituted for a threonine residue at amino acid 265 of SEQ ID NO:3; z) A tyrosine substituted for an aspartic acid residue at amino acid 292 of SEQ ID NO:3; aa) A serine substituted for a glycine residue at amino acid 293 of SEQ ID NO:3; bb) An alanine substituted for a valine residue at amino acid 317 of SEQ ID NO:3; cc) An asparagine substituted for a serine residue at amino acid 335 of SEQ ID NO:3; dd) A serine substituted for an alanine residue at amino acid 355 of SEQ ID NO:3; ee) An asparagine substituted for an isoleucine residue at amino acid 364 of SEQ ID NO:3; or, ff) A valine substituted for an alanine residue at amino acid 382 of SEQ ID NO:3. 10 A recombinant nucleic acid encoding the polypeptide as claimed in claim 1, wherein said nucleic acid further encodes one or more of the following: a) An aspartic acid substituted for a glycine at amino acid 4 of SEQ ID NO:3; b) A serine substituted for a proline at amino acid 12 of SEQ ID NO:3; c) An alanine substituted for the threonine residue at amino acid 47 of SEQ ID NO:3; d) An aspartic acid substituted for a glycine at amino acid 66 of SEQ ID NO:3; e) A methionine substituted for a threonine at amino acid 68 of SEQ ID NO:3; f) A tyrosine substituted for the aspartic acid residue at amino acid 73 of SEQ ID NO:3; g) A methionine substituted for the threonine residue at amino acid 76 of SEQ ID NO:3; h) A cysteine substituted for the glycine residue at amino acid 81 of SEQ ID NO: 3; i) A leucine substituted for the proline residue at amino acid 87 of SEQ ID NO:3; j) A valine substituted for the alanine residue at amino acid 89 of SEQ ID NO:3; k) A leucine substituted for the proline residue at amino acid 127 of SEQ ID NO:3; 1) A glutamic acid substituted for an aspartic acid residue at amino acid 133 of SEQ ID NO:3; m) An aspartic acid substituted for a glycine residue at amino acid 139 of SEQ ID NO:3; n) A cysteine substituted for a glycine residue to amino acid 157 of SEQ ID NO:3; o) A serine substituted for a glycine residue at amino acid 169 of SEQ ID NO:3; p) A threonine substituted for an alanine residue at amino acid 188 of SEQ ID NO:3; q) A phenylalanine substituted for a leucine residue at amino acid 194 of SEQ ID NO:3; r) A serine substituted for a glycine residue at amino acid 195 of SEQ ID NO:3; s) A tyrosine substituted for an aspartic acid residue at amino acid 205 of SEQ ID NO:3; t) A valine substituted for an alanine residue at amino acid 209 of SEQ ID NO:3; u) A threonine substituted for an alanine residue at amino acid 225 of SEQ ID NO:3; v) A valine substituted for an alanine residue at amino acid 235 of SEQ ID NO:3; w) An alanine substituted for a valine residue at amino acid 239 of SEQ ID NO:3; x) A threonine substituted for a lysine residue at amino acid 260 of SEQ ID NO:3; y) A methionine substituted for a threonine residue at amino acid 265 of SEQ ID NO:3; z) A tyrosine substituted for an aspartic acid residue at amino acid 292 of SEQ ID NO:3; aa) A serine substituted for a glycine residue at amino acid 293 of SEQ ID NO:3; bb) An alanine substituted for a valine residue at amino acid 317 of SEQ ID NO:3; cc) An asparagine substituted for a serine residue at amino acid 335 of SEQ ID NO:3; dd) A serine substituted for an alanine residue at amino acid 355 of SEQ ID NO:3; ee) An asparagine substituted for an isoleucine residue at amino acid 364 of SEQ ID NO:3; or, ff) A valine substituted for an alanine residue at amino acid 382 of SEQ ID NO:3. 11. A method for producing a recombinant polypeptide with herbicide resistance activity, comprising culturing the host cell as claimed in claim 6 under conditions in which a nucleic acid molecule encoding the polypeptide is expressed, said polypeptide being selected from the group consisting of: a) a polypeptide comprising the amino acid sequence of SEQ ID NO:3; b) a polypeptide encoded by the nucleic acid sequence of SEQ ID NO: 1 or 2; c) a polypeptide comprising an amino acid sequence having at least 95% sequence identity to a polypeptide with the amino acid sequence of SEQ ID NO:3, wherein said polypeptide has herbicide resistance activity; and d) a polypeptide encoded by a nucleic acid molecule comprising a nucleotide sequence having at least 95% sequence identity to the nucleic acid sequence of SEQ ID NO:1 or 2, wherein said polypeptide has herbicide resistance activity; and, e) a polypeptide that is encoded by the herbicide resistance nucleotide sequence of the DNA insert of the plasmid deposited as Accession No. NRRL B-30804. 12. A method for conferring resistance to an herbicide in a plant, said method comprising transforming said plant with a DNA construct, said construct comprising a promoter that drives expression in a plant cell operably linked with a nucleotide sequence as claimed in claim 1, and regenerating a transformed plant. 13. The method as claimed in claim 12, wherein said herbicide is a glyphosate. ABSTRACT The invention discloses a recombinant nucleic acid molecule encoding a 5- enolpyruvylshikimate-3-phosphate synthase enzyme selected from the group consisting of: a) a nucleic acid molecule comprising the nucleotide sequence of SEQ ID NO:1 or 2, or a complement thereof; b) a nucleic acid molecule comprising a nucleotide sequence having at least 95% sequence identity to the nucleotide sequence of SEQ ID NO: 1 or 2, or a complement thereof, wherein said nucleotide sequence encodes a polypeptide having herbicide resistance activity; c) the herbicide resistance nucleotide sequence of the DNA insert of the plasmid deposited as Accession No. NRRL B-30804, or a complement thereof; d) a nucleic acid molecule which encodes a polypeptide comprising the amino acid sequence of SEQ ID NO:3; and, e) a nucleic acid molecule comprising a nucleotide sequence encoding a polypeptide having at least 95% amino acid sequence identity to the amino acid sequence of SEQ ID NO:3, wherein said polypeptide has herbicide resistance activity. The invention is also for a vector comprising said molecule and a polypeptide encoded by it having herbicide resistance.

Documents:

02500-kolnp-2007-abstract.pdf

02500-kolnp-2007-assignment.pdf

02500-kolnp-2007-claims.pdf

02500-kolnp-2007-correspondence others-1.1.pdf

02500-kolnp-2007-correspondence others.pdf

02500-kolnp-2007-description complete.pdf

02500-kolnp-2007-drawings.pdf

02500-kolnp-2007-form 1.pdf

02500-kolnp-2007-form 3-1.1.pdf

02500-kolnp-2007-form 3.pdf

02500-kolnp-2007-form 5.pdf

02500-kolnp-2007-gpa.pdf

02500-kolnp-2007-international publication.pdf

02500-kolnp-2007-international search report.pdf

02500-kolnp-2007-priority document.pdf

2500-KOLNP-2005-(04-06-2013)-ABSTRACT.pdf

2500-KOLNP-2005-(04-06-2013)-CLAIMS.pdf

2500-KOLNP-2005-(04-06-2013)-CORRESPONDENCE.pdf

2500-KOLNP-2005-(04-06-2013)-FORM 1.pdf

2500-KOLNP-2005-(04-06-2013)-FORM 2.pdf

2500-KOLNP-2007-(01-06-2012)-CORRESPONDENCE.pdf

2500-KOLNP-2007-(04-07-2012)-AMANDED CLAIMS.pdf

2500-KOLNP-2007-(04-07-2012)-CORRESPONDENCE.pdf

2500-KOLNP-2007-(04-07-2012)-FORM-13.pdf

2500-KOLNP-2007-(04-07-2012)-OTHERS.pdf

2500-KOLNP-2007-(20-03-2012)-ABSTRACT.pdf

2500-KOLNP-2007-(20-03-2012)-AMANDED CLAIMS.pdf

2500-KOLNP-2007-(20-03-2012)-AMANDED PAGES OF SPECIFICATION.pdf

2500-KOLNP-2007-(20-03-2012)-DESCRIPTION (COMPLETE).pdf

2500-KOLNP-2007-(20-03-2012)-DRAWINGS.pdf

2500-KOLNP-2007-(20-03-2012)-EXAMINATION REPORT REPLY RECEIVED.pdf

2500-KOLNP-2007-(20-03-2012)-FORM-1.pdf

2500-KOLNP-2007-(20-03-2012)-FORM-13.pdf

2500-KOLNP-2007-(20-03-2012)-FORM-2.pdf

2500-KOLNP-2007-(20-03-2012)-FORM-3.pdf

2500-KOLNP-2007-(20-03-2012)-FORM-5.pdf

2500-KOLNP-2007-(20-03-2012)-OTHERS.pdf

2500-KOLNP-2007-(20-03-2012)-PETITION UNDER RULE 137-1.pdf

2500-KOLNP-2007-(20-03-2012)-PETITION UNDER RULE 137.pdf

2500-kolnp-2007-form 18.pdf

abstract-02500-kolnp-2007.jpg